Fractyl Health (GUTS) News Today $1.64 -0.01 (-0.30%) Closing price 03:36 PM EasternExtended Trading$1.64 0.00 (0.00%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Fractyl Health Reports 3-Month REVEAL-1 Data Suggesting Durable Weight Maintenance, Stock Down - NasdaqJune 25, 2025 | nasdaq.comPromising Data from Fractyl Health’s Reveal-1 Study Boosts Confidence in Revita Treatment Ahead of Pivotal Remain-1 StudyJune 25, 2025 | tipranks.comFractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance TherapyJune 23, 2025 | globenewswire.comFractyl Health Presents New Data at the American Diabetes Association's 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical ModelsJune 23, 2025 | globenewswire.comFractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal ResurfacingJune 19, 2025 | finance.yahoo.comFractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific SessionsJune 13, 2025 | globenewswire.comInnovative Weight Management Solution Drives Buy Rating for Fractyl HealthJune 4, 2025 | tipranks.comFractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers NationwideJune 4, 2025 | globenewswire.comFractyl Health Submits Clinical Trial Application in EuropeMay 19, 2025 | tipranks.comFractyl Health Unveils Promising Gene Therapy DataMay 19, 2025 | tipranks.comFractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 DiabetesMay 19, 2025 | globenewswire.comFractyl Health, Inc.: Fractyl Health Announces First Quarter 2025 Financial Results and Business UpdatesMay 19, 2025 | finanznachrichten.deFractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025May 17, 2025 | globenewswire.comFractyl Health’s Earnings Call: Clinical Progress Amid Financial ConcernsMay 15, 2025 | tipranks.comEarnings call transcript: Fractyl Health’s Q1 2025 shows rising R&D costsMay 15, 2025 | investing.comFractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q1 2025 Earnings Call TranscriptMay 14, 2025 | insidermonkey.comFractyl signals accelerated enrollment for REMAIN-1 study while advancing Rejuva clinical milestonesMay 13, 2025 | msn.comFractyl Health, Inc. (GUTS) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comFractyl Health Announces First Quarter 2025 Financial Results and Business UpdatesMay 13, 2025 | globenewswire.comFractyl Health (GUTS) to Release Quarterly Earnings on MondayMay 7, 2025 | marketbeat.comFractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor ConferenceMay 6, 2025 | globenewswire.comFractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual MeetingApril 28, 2025 | globenewswire.comCanaccord Genuity Initiates Coverage of Fractyl Health (GUTS) with Buy RecommendationApril 16, 2025 | msn.comFractyl Health reports early data from REVEAL-1 cohort of REMAIN-1 studyApril 2, 2025 | markets.businessinsider.comFractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025April 2, 2025 | insidermonkey.comFractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 DiscontinuationApril 1, 2025 | globenewswire.comWilliam Bradley Acquires 16,129 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) StockMarch 18, 2025 | marketbeat.comInsider Buying: Fractyl Health, Inc. (NASDAQ:GUTS) Director Acquires 16,129 Shares of StockMarch 18, 2025 | insidertrades.comFractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q4 2024 Earnings Call TranscriptMarch 9, 2025 | insidermonkey.comFractyl Health, Inc. (NASDAQ:GUTS) Sees Large Increase in Short InterestMarch 5, 2025 | marketbeat.comFRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly EarningsMarch 5, 2025 | nasdaq.comFractyl Health’s Earnings Call: Progress Amid ChallengesMarch 4, 2025 | tipranks.comFractyl Health Reports 2024 Financial Results and Strategic ProgressMarch 3, 2025 | tipranks.comFractyl Health reports Q4 EPS (52c), consensus (44c)March 3, 2025 | markets.businessinsider.comFractyl Health files $300M mixed securities shelfMarch 3, 2025 | markets.businessinsider.comFractyl Health, Inc. (GUTS) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comFractyl Health (NASDAQ:GUTS) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSMarch 3, 2025 | marketbeat.comFractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 3, 2025 | globenewswire.comFractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025February 24, 2025 | globenewswire.comFractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Decrease in Short InterestFebruary 19, 2025 | marketbeat.comBeyond GLP-1s? This biotech is exploring longer-term metabolic treatmentsFebruary 10, 2025 | finance.yahoo.comBank of America Securities Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)February 5, 2025 | markets.businessinsider.comFractyl Health price target lowered to $6 from $13 at BofAFebruary 5, 2025 | markets.businessinsider.comFractyl Health, Inc. (NASDAQ:GUTS) Insider Sells $40,446.26 in StockFebruary 4, 2025 | insidertrades.comJay David Caplan Sells 22,346 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) StockFebruary 3, 2025 | marketbeat.comInsider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of StockFebruary 3, 2025 | marketbeat.comMorgan Stanley Lowers Fractyl Health (NASDAQ:GUTS) Price Target to $10.00February 3, 2025 | marketbeat.comFractyl Health, Inc. (GUTS) Receives a Buy from Morgan StanleyFebruary 2, 2025 | markets.businessinsider.comFractyl Health announces increased focus on Revita, Rejuva programsJanuary 31, 2025 | markets.businessinsider.comFractyl Health Reprioritizes Focus on REMAIN-1 StudyJanuary 31, 2025 | tipranks.com Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address GUTS Media Mentions By Week GUTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GUTS News Sentiment▼0.000.54▲Average Medical News Sentiment GUTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GUTS Articles This Week▼02▲GUTS Articles Average Week Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Semler Scientific News Treace Medical Concepts News NeuroPace News Outset Medical News ClearPoint Neuro News Perspective Therapeutics News Nano-X Imaging News Sanuwave Health News Nyxoah News ZimVie News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GUTS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GUTS Stock Alerts